Assyro AI

Orange Book product · Brand (NDA)

PRESTALIA

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

Brand (NDA)NDA 205003DISCN ADHERA

At a glance

Jan 21, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 21, 2015

    11 yr 7 mo ago

  2. Today

  3. Patent 7846961 expires

    Listed drug substance patent expiration.

    Oct 05, 2029

    in 3 yr 4 mo

Pharmaceutical detail

Active ingredient

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

Strength

EQ 2.5MG BASE;3.5MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 205003

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7846961Oct 05, 2029in 3 yr 4 mo
SubstanceProductU-3
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.